Physician profile
John M Wilson
NPI 1639673924
$2,685.51
in general payments reported to CMS, 2019-2025
11 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $406 · 2022: $375 · 2023: $917 · 2024: $751 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,904.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $683.87 | 2021-2024 | |
| Medtronic, INC. | $680.26 | 2021-2024 | Mazor X System, Intellis Adaptivestim, Unid_pass |
| Orthofix Medical, INC. | $330.32 | 2023-2024 | Trinity Elite |
| Stryker Corporation | $314.98 | 2023-2025 | Adherus Autospray Dural Sealant, Universal Neuro 3, Duramatrix |
| Microvention, INC. | $161.28 | 2021-2023 | Lvis Junior, Headway Advanced Soft |
| Bioventus LLC | $137.35 | 2023 | Bonescalpel |
| Globus Medical, INC. | $130.00 | 2022 | |
| Penumbra, INC. | $111.50 | 2023 | Benchmark |
| Boston Scientific Corporation | $80.32 | 2025 | General - Pain Management |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $37.20 | 2024 | Caplyta |
| Innovation Technologies INC | $18.43 | 2024 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.